Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
August 26, 2004
RemedyTemp, Inc.
California | 000-20831 | 95-2890471 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
101 Enterprise
Aliso Viejo, California 92656
Registrant’s telephone number, including area code: (949) 425-7600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 8.01. OTHER EVENTS | ||||||||
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Table of Contents
ITEM 8.01. OTHER EVENTS
On August 26, 2004, RemedyTemp, Inc. (the “Company”) filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission. A copy of the Company’s press release with respect thereto is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
Exhibit 99.1, as listed on the Exhibit Index (following this Report’s signature page), is filed with this Report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
REMEDYTEMP, INC. (Registrant) | ||||
Date: August 26, 2004 | By: | /s/ Greg Palmer | ||
Greg Palmer | ||||
President and Chief Executive Officer | ||||
2